Buy Vildagliptin Powder Anti-diabetic Drug Medical Grade for Type 2 Diabetes Online
What is Vildagliptin?
Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus
Vildagliptin Certificate of Analysis
| Product name |
Vildagliptin |
| CAS No. |
274901-16-5 |
Outer Packing |
1kg/bag |
| Production date |
Jan 20th 2018 |
Shelf life |
2 years |
| Standard adopted |
Enterprise Standard |
| Items of analysis |
Specification |
Results |
| appearance |
white crystalline powder |
white crystalline powder |
| identification |
identical to the IR spectrum of standard |
pass |
| water |
≤1.0% |
0.16% |
| melt point |
148℃~150℃ |
148.2℃~149.7℃ |
| residue on ignition |
≤0.1% |
0.09% |
| heavy metals |
≤20ppm |
〈20ppm |
| max single impurity |
≤0.2% |
0.14% |
| total impurities |
≤1.0% |
0.16% |
| Ee |
≥98.0% |
99.8% |
| acetonitrile |
≤410ppm |
160ppm |
| dichloromethane |
≤600ppm |
16ppm |
| isopropyl alcohol |
≤5000ppm |
3136ppm |
| Conclusion |
Qualified |
Vildagliptin Adverse effects
Adverse effects observed in clinical trials include nausea, hypoglycemia, tremor, headache and dizziness. Rare cases of hepatoxicity have been reported.
